Who provides growth debt?

Growth debt is provided by several kinds of lender: specialist bank teams, private credit and venture debt funds, large institutional investment managers, US business development companies, public development institutions and specialist alternative lenders.

The category matters because a lender’s capital, regulation, mandate and target return can influence the companies it will finance and the terms it can offer. It does not tell you whether that lender will be a good partner. Two providers in the same category can behave very differently.

The lender landscape at a glance

Specialist banks

Some banks have teams dedicated to innovation, technology, life sciences or high-growth companies. They can provide venture debt or growth lending to businesses that would not fit the bank’s standard commercial loan process.

A bank may fund loans from its balance sheet and operate within detailed credit, capital and regulatory rules. It may also want a broader relationship covering deposits, payments, foreign exchange or treasury services. That relationship can be useful: the bank understands the company’s cash movements and can provide several products through one organisation.

Bank funding is not automatically cheaper, and bank terms are not automatically rigid. Pricing and flexibility depend on risk, competition, the relationship and the specific credit team. Ask who controls approvals and amendments. The team that originates the loan may need consent from a separate credit committee when circumstances change.

A bank may also be more sensitive to deposit concentration, sector limits or regulatory changes than a founder expects. Understand whether keeping cash with the lender is a contractual requirement and what rights the bank has over those accounts.

Specialist venture debt and growth credit funds

Specialist funds raise capital from investors such as pension funds, insurers, endowments, family offices and other institutions. The fund then lends that capital according to an agreed mandate: for example, stage, sector, geography, loan size and target return.

Because these funds are built for private lending, they can often tailor tranches, repayment profiles, covenants and equity-linked features around a growth company. They may have deep experience of software, life sciences, climate technology or another specialist market.

The flexibility has a price. A fund’s investors expect a return appropriate to the risk, which may combine cash interest, fees, payment-in-kind interest and warrants. Payment-in-kind interest is added to the loan balance instead of paid immediately. A warrant gives the lender a right linked to future shares and can create dilution.

The fund’s structure matters too. A drawdown fund normally has a fixed life: investors commit capital, the manager invests it and later returns it. An evergreen vehicle is designed to keep operating rather than wind down on a fixed date. These structures can affect the lender’s appetite for long maturities, extensions, follow-on lending or holding a troubled loan.

Do not assume that a fund near the end of its life will necessarily force an exit; legal structures and manager options vary. Do ask how much uncalled capital remains, whether follow-on funding is available and who would own the loan through its full term.

Large institutional credit managers

Large asset managers may operate several credit strategies under one brand: mainstream direct lending, growth credit, opportunistic credit, asset-based finance and others. They can bring scale, sector teams and the ability to finance larger companies or grow with a borrower.

The brand alone does not identify the mandate. A growth company should establish which fund or balance sheet will make the loan. Different strategies inside the same manager can have different return requirements, investment periods, concentration limits and decision makers.

Scale can support larger facilities and follow-on capital, but a borrower may represent a small part of a very large portfolio. Ask who will manage the relationship after closing, how frequently the credit committee reviews the company and whether the original deal team remains involved in amendments.

Business development companies

A business development company, usually shortened to BDC, is a US investment vehicle rather than a type of loan. BDCs are closed-end funds designed to invest in small and developing businesses. Some specialise in venture and growth lending; others focus on established middle-market borrowers.

Some BDCs are listed on a stock exchange, while others are non-traded. They may be managed internally or by an external asset manager. Their portfolios and financial information can be visible through public filings, which gives borrowers and advisers another source of information about concentration, loan performance and strategy.

For a UK or European borrower, a BDC may matter when the provider has an international mandate or the company has significant US operations. The label does not guarantee a particular product, price or risk appetite. Confirm the actual investment strategy making the loan.

Public and development institutions

Public institutions can provide growth and venture debt directly or help private lenders provide it through guarantees, funding and investment in debt funds. Their purpose is usually to address a financing gap or support policy goals such as innovation, regional development or the transition to a lower-carbon economy.

The European Investment Bank, for example, provides long-term venture debt to eligible innovative companies and links part of its return to company performance. The British Business Bank supports lending through programmes, guarantees and investments in finance providers; many of its schemes are delivered by accredited private lenders rather than by the Bank lending directly to every company.

Public backing does not usually make debt a grant. The borrower remains responsible for repayment unless the specific programme says otherwise. Eligibility can also depend on turnover, geography, sector, use of proceeds, research spending or other policy conditions.

These providers can offer valuable scale and patient structures, but processes may involve detailed eligibility, due diligence and reporting. A company with a time-critical need should test the timetable early.

Alternative and specialty lenders

Some growth companies are better served by a product tied to a particular asset or cash-flow stream than by a general corporate term loan. Providers include asset-based lenders, receivables and invoice finance firms, equipment lessors, recurring-revenue lenders and other specialist platforms.

An asset-based facility is sized mainly against eligible assets such as receivables, inventory or equipment. A recurring-revenue product may use contracted or subscription income. These products can provide useful flexibility when the company has a clear asset or revenue base but does not fit conventional profit tests.

Alternative does not mean unsecured or light on obligations. The lender may control collections, apply eligibility rules, reduce the amount available when asset quality changes, require a cash sweep or take broad security. A cash sweep directs defined surplus cash towards repayment.

Some products are marketed with quick headline pricing but include platform fees, fixed charges or repayments that imply a different effective cost. Compare total cash paid and the timing of payments under realistic scenarios.

How the capital source shapes the offer

Every lender must satisfy the people or institutions supplying its capital. A bank manages deposits, wholesale funding, regulatory capital and credit limits. A private fund follows documents agreed with its investors. A BDC operates within its legal and investment framework. A development institution follows a public mandate.

These constraints can influence:

• the minimum and maximum loan size;
• the sectors, countries and company stages the lender can support;
• whether the lender needs present profitability or can underwrite future growth;
• the interest, fees and equity participation it seeks;
• how long it can commit capital and whether it can fund later tranches;
• its ability to amend, extend, refinance or hold a loan after a problem; and
• the reporting it requires from the borrower.

A mandate can be as important as credit appetite. A lender may like the company but be unable to proceed because the facility is too small, the sector limit is full or the investment period is ending.

How to choose the right lender type

Start with the company’s facts rather than a list of provider names. Define the amount needed, when it must be available, the use of proceeds, the repayment route and the downside case.

Then ask each potential lender:

1. 1Which part of your mandate makes our company a fit?
2. 2What is the source and expected duration of the capital behind the loan?
3. 3How much is committed at signing, and who controls later tranches?
4. 4What return do you expect across interest, fees, warrants and other charges?
5. 5What deposits, banking services, security or account controls are required?
6. 6Who makes amendment and enforcement decisions after closing?
7. 7Can you provide follow-on capital, and from which vehicle?
8. 8Can we speak to borrowers that performed to plan and borrowers that needed flexibility?
9. 9What happens if our next funding round or route to profitability takes six months longer?

The bottom line

Growth debt comes from a varied market, not one lender category. Banks, specialist funds, institutional managers, BDCs, development institutions and specialty finance providers can all participate, sometimes in the same transaction.

Their capital source and mandate influence fit, structure and behaviour, but labels are only a starting point. Compare the team, decision process, complete economics and downside conduct of each actual provider.

The best lender is not simply the one offering the largest facility or lowest headline margin. It is the provider whose capital and approach remain compatible with the company when the plan changes.

Where to go next

• Choosing a growth lender helps compare lender fit, behaviour and decision making.
• How growth lenders assess companies sets out the underwriting questions behind a lender’s decision.
• Venture debt vs traditional bank lending shows how specialist venture lending differs from conventional bank credit.
• How to raise growth debt maps the process from preparation to signed facility.